“To me the RemovAid™ device...is good to be used and I wish that we can get it in our country - that would ease our work."
Ssentongo Gertrude, Midwife
Mulago National Referral Hospital, Uganda
The Bill & Melinda Gates Foundation
The ACCESS CI project was initiated to take the RemovAid™ from early prototypes to a device ready for clinical use.
The device's safety was confirmed and the design optimized through pilot studies at Karolinska Institutet in Sweden.
A 3 arm randomized controlled trial (Safe ACCESS) was performed at Kawempe National Referral Hospital in Uganda. Results confirmed the device as a safe, acceptable alternative to standard removal techniques. The study concluded that the device could potentially be used to expand access to implant removal services.
Sex og samfunn
The ACCESS Norway project was initiated to evaluate the benefits RemovAid can provide to women and healthcare providers in Oslo, Norway.
With access to a busy youth clinic and highly skilled providers experienced in sexual and reproductive health, we are able to see first-hand how the device performs in a clinical setting.